Monthly Archives: April 2014

Berlinger Special News

Berlinger – Special News Berlinger Special AG is a complete supplier of professional doping and drug control equipment. In 1998 out of a niche product of Berlinger & Co. AG’s grew an independent subsidiary company. At the centre of Berlinger Special AG’s range of products and services is the BEREG KIT. It ensures the secure

Continue Reading →

TP3 News

TP3 – NEWS: Pharmaceutical Shippers Adopt Radical New Pallet Protection Pune, INDIA – Leading shippers of controlled ambient pharmaceuticals are protecting temperature sensitive pallets with a revolutionary new solar material specifically designed to reflect direct sun and prevent air exchange during risk points and temperature spikes in the supply chain. The innovative new SilverSkin™ material,

Continue Reading →

Berlinger News

BERLINGER – NEWS: Over the years, we at Berlinger & Co. AG have developed with you. During that time, in order to meet the needs of our valued customers, we have continuously increased the number of our employees. Progress demands ideas, so we are especially pleased that we have been able to increase our staffing

Continue Reading →

Ethicon Biosurgery Ireland announce plans to develop new manufacturing facility in Limerick

Ethicon Biosurgery Ireland, part of the Johnson & Johnson Group,  announced plans to develop an €80 million state-of-the-art manufacturing facility providing approximately 270 jobs at the National Technology Park, Plassey, Limerick. Ethicon Biosurgery is a worldwide leader in hemostasis and sealing solutions.  The new plant will manufacture EVARREST™ Sealant Matrix, a product that helps stop

Continue Reading →

Alexion Pharmaceuticals incrases operations in Ireland.

Alexion Pharma International Trading, a subsidiary of Alexion Pharmaceuticals, Inc., announced plans to expand its operations in Ireland following the acquisition of a new site in West Dublin. The Company expects that this expansion will create approximately 200 new jobs at Alexion as part of an investment of approximately €75 million in this new site over

Continue Reading →

Regulation Updates

Update to the revised guidelines on Good Distribution Practice (GDP) of Medicinal Products for Human Use The revised EU GDP Guidelines published in the Official Journal of the European Union by the EU Commission on the 7 March 2013 (2013/C 68/01) and which replaced the GDP Guidelines published in 1994 (94/C 63/03) have been updated.

Continue Reading →

Kalibox News

KALIBOX – NEWS: Impact of GDP on 15/25°C shipments The recently issued new GDP guidelines increase the requirements for Controlled Room Temperature (CRT) products pushing many laboratories to analyze their risks and to consider more efficient protections for their most sensitive shipments. Accompanying this change, Kalibox has completed its range of qualified solutions in order

Continue Reading →